BioNTech SE (BNTX) Raw Materials (2018 - 2021)
BioNTech SE's Raw Materials history spans 4 years, with the latest figure at $284.0 million for Q4 2021.
- For Q4 2021, Raw Materials rose 437.78% year-over-year to $284.0 million; the TTM value through Dec 2021 reached $284.0 million, up 437.78%, while the annual FY2021 figure was $284.0 million, 437.78% up from the prior year.
- Raw Materials for Q4 2021 was $284.0 million at BioNTech SE, up from $52.8 million in the prior quarter.
- Across five years, Raw Materials topped out at $284.0 million in Q4 2021 and bottomed at $5.1 million in Q4 2018.
- The 4-year median for Raw Materials is $30.9 million (2020), against an average of $87.8 million.
- The largest annual shift saw Raw Materials soared 77.72% in 2019 before it soared 481.86% in 2020.
- A 4-year view of Raw Materials shows it stood at $5.1 million in 2018, then skyrocketed by 77.72% to $9.1 million in 2019, then skyrocketed by 481.86% to $52.8 million in 2020, then surged by 437.78% to $284.0 million in 2021.
- Per Business Quant, the three most recent readings for BNTX's Raw Materials are $284.0 million (Q4 2021), $52.8 million (Q4 2020), and $9.1 million (Q4 2019).